The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Blood Vessel Prosthesis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Blood Vessel Prosthesis


High impact information on Blood Vessel Prosthesis


Chemical compound and disease context of Blood Vessel Prosthesis


Biological context of Blood Vessel Prosthesis


Anatomical context of Blood Vessel Prosthesis


Associations of Blood Vessel Prosthesis with chemical compounds


Gene context of Blood Vessel Prosthesis


Analytical, diagnostic and therapeutic context of Blood Vessel Prosthesis


  1. Protective effect of warfarin in arterial thrombosis: evidence from a vascular prosthesis model in rats. Reyers, I., de Gaetano, G., Donati, M.B. Thromb. Haemost. (1983) [Pubmed]
  2. Expression of genes for platelet-derived growth factor in adult human venous endothelium. A possible non-platelet-dependent cause of intimal hyperplasia in vein grafts and perianastomotic areas of vascular prostheses. Limanni, A., Fleming, T., Molina, R., Hufnagel, H., Cunningham, R.E., Cruess, D.F., Sharefkin, J.B. J. Vasc. Surg. (1988) [Pubmed]
  3. Blood hemolysis by PTFE and polyurethane vascular prostheses in an in vitro circuit. Martz, H., Paynter, R., Losier, M., Domurado, D., Forest, J.C., Guidoin, R. J. Biomed. Mater. Res. (1987) [Pubmed]
  4. Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors. Dartevelle, P.G., Chapelier, A.R., Pastorino, U., Corbi, P., Lenot, B., Cerrina, J., Bavoux, E.A., Verley, J.M., Neveux, J.Y. J. Thorac. Cardiovasc. Surg. (1991) [Pubmed]
  5. The acute phase response following implantation of triclosan-bonded vascular prostheses. Hernandez-Richter, T.M., Wichmann, M.W., Schrödl, W., Angele, M.K., Heinritzi, K., Schildberg, F.W. Clin. Exp. Med. (2001) [Pubmed]
  6. Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Noishiki, Y., Tomizawa, Y., Yamane, Y., Matsumoto, A. Nat. Med. (1996) [Pubmed]
  7. Implanted vascular prostheses generate prostacyclin. Sinzinger, H., Silberbauer, K., Winter, M., Auerswald, W. Lancet (1978) [Pubmed]
  8. Expandable tubular stents for treatment of arterial occlusive diseases: experimental and clinical results. Work in progress. Strecker, E.P., Liermann, D., Barth, K.H., Wolf, H.R., Freudenberg, N., Berg, G., Westphal, M., Tsikuras, P., Savin, M., Schneider, B. Radiology. (1990) [Pubmed]
  9. Binding of tissue plasminogen activator to vascular grafts. Harvey, R.A., Kim, H.C., Pincus, J., Trooskin, S.Z., Wilcox, J.N., Greco, R.S. Thromb. Haemost. (1989) [Pubmed]
  10. The vascular prosthesis without pseudointima prepared by antithrombogenic phospholipid polymer. Yoneyama, T., Sugihara, K., Ishihara, K., Iwasaki, Y., Nakabayashi, N. Biomaterials (2002) [Pubmed]
  11. Nitric oxide prevents the bacterial translocation and inhibits the systemic inflammatory response produced by implantation of a vascular prosthesis followed by Zymosan A. Lozano, F.S., Barros, M.B., Fresnadillo, M.J., García-Criado, F.J., Gomez-Alonso, A. Inflamm. Res. (2005) [Pubmed]
  12. Adsorption of basic fibroblast growth factor onto Dacron vascular prosthesis and its biological efficacy. Takahashi, K. Artificial organs. (1997) [Pubmed]
  13. Increase in circulating endothelial progenitor cells after aortic aneurysm repair. Eizawa, T., Ikeda, U., Murakami, Y., Matsui, K., Yoshioka, T., Suzuki, C., Takahashi, M., Muroi, K., Kamisawa, O., Fuse, K., Shimada, K. Heart and vessels. (2004) [Pubmed]
  14. Differentiation of vascular pseudointima under normal and disturbed blood flow conditions: ultrastructural observations in the rat. van der Lei, B., Schakenraad, J.M. Cell Tissue Res. (1988) [Pubmed]
  15. Differentiation of vascular prostheses in dogs with serial tests of in vivo platelet reactivity. Clagett, G.P., Graeber, G.M., Robinowitz, M., Langloss, J.M., Ramwell, P.W. Surgery (1984) [Pubmed]
  16. Biocompatibility of the Vascugraft: evaluation of a novel polyester urethane vascular substitute by an organotypic culture technique. Guidoin, R., Sigot, M., King, M., Sigot-Luizard, M.F. Biomaterials (1992) [Pubmed]
  17. Accelerated healing of cardiovascular textiles promoted by an RGD peptide. Tweden, K.S., Harasaki, H., Jones, M., Blevitt, J.M., Craig, W.S., Pierschbacher, M., Helmus, M.N. J. Heart Valve Dis. (1995) [Pubmed]
  18. Transmural endothelialization of vascular prostheses is regulated in vitro by Fibroblast Growth Factor 2 and heparan-like molecule. Desgranges, P., Barritault, D., Caruelle, J.P., Tardieu, M. The International journal of artificial organs. (1997) [Pubmed]
  19. Polyurethane vascular prostheses decreases neointimal formation compared with expanded polytetrafluoroethylene. Jeschke, M.G., Hermanutz, V., Wolf, S.E., Köveker, G.B. J. Vasc. Surg. (1999) [Pubmed]
  20. A comparison of isobutyl 2-cyanoacrylate glue, fibrin adhesive, and oxidized regenerated cellulose for control of needle hole bleeding from polytetrafluoroethylene vascular prostheses. Barbalinardo, R.J., Citrin, P., Franco, C.D., Hobson, R.W. J. Vasc. Surg. (1986) [Pubmed]
  21. Polyglactin 910/polydioxanone bicomponent totally resorbable vascular prostheses. Greisler, H.P., Endean, E.D., Klosak, J.J., Ellinger, J., Dennis, J.W., Buttle, K., Kim, D.U. J. Vasc. Surg. (1988) [Pubmed]
  22. Reduction in deposition of indium 111-labeled platelets after autologous endothelial cell seeding of Dacron aortic bifurcation grafts in humans: a preliminary report. Ortenwall, P., Wadenvik, H., Kutti, J., Risberg, B. J. Vasc. Surg. (1987) [Pubmed]
  23. Heparin coating of vascular prostheses reduces thromboemboli. Ritter, E.F., Kim, Y.B., Reischl, H.P., Serafin, D., Rudner, A.M., Klitzman, B. Surgery (1997) [Pubmed]
  24. Rupture of pseudointima in an implanted vascular prosthesis: immunohistological study of plasminogen activators and matrix metalloproteinases. Urayama, H., Katada, S., Kasashima, F., Tanaka, Y., Kawasuji, M., Watanabe, Y. The Journal of cardiovascular surgery. (2000) [Pubmed]
  25. Sustained release of basic fibroblast growth factor from the synthetic vascular prosthesis using hydroxypropylchitosan acetate. Yamamura, K., Sakurai, T., Yano, K., Nabeshima, T., Yotsuyanagi, T. J. Biomed. Mater. Res. (1995) [Pubmed]
  26. Thrombomodulin activity of fat-derived microvascular endothelial cells seeded on expanded polytetrafluorethylene. Hedeman Joosten, P.P., Verhagen, H.J., Heijnen-Snyder, G.J., Sixma, J.J., de Groot, P.G., Eikelboom, B.C., Elisen, M.G. J. Vasc. Res. (1999) [Pubmed]
  27. Platelet reactivity in vivo in dogs with arterial prostheses seeded with endothelial cells. Clagett, G.P., Burkel, W.E., Sharefkin, J.B., Ford, J.W., Hufnagel, H., Vinter, D.W., Kahn, R.H., Graham, L.M., Stanley, J.C., Ramwell, P.W. Circulation (1984) [Pubmed]
  28. Rapid cellular luminal coverage of Dacron inferior vena cava prostheses in dogs by immediate seeding of autogenous endothelial cells derived from omental tissue: results of a preliminary trial. Wang, Z.G., Du, W., Li, G.D., Pu, L.Q., Sharefkin, J.B. J. Vasc. Surg. (1990) [Pubmed]
  29. Complement activation by vascular prostheses and its role in progression of arteriosclerotic lesions. Miyauchi, M., Shionoya, S. Angiology. (1988) [Pubmed]
WikiGenes - Universities